Receptos, Inc.(Nasdaq: RCPT) 10.5% HIGHER; Celgene Corporation (Nasdaq: CELG) and Receptos, Inc.(Nasdaq: RCPT) announced the signing of a definitive agreement in which Celgene has agreed to acquire Receptos. Under the terms of the merger agreement, Celgene will pay $232.00 per share in cash, or a total of approximately $7.2 billion, net of cash acquired.
Celsion Corp (NASDAQ: CLSN) 10.5% HIGHER; Maxim Group initiates coverage with a Buy rating
Allegheny Technologies (NYSE: ATI) 9.3% LOWER; commented that, due primarily to challenging business conditions in its Flat Rolled Products business and further weakening in demand from the oil and gas market,